Prediction of individual long-term outcomes in smoking cessation trials using frailty models

Yimei Li, E. Paul Wileyto, Daniel F. Heitjan

Research output: Contribution to journalArticle

4 Scopus citations

Abstract

In smoking cessation clinical trials, subjects commonly receive treatment and report daily cigarette consumption over a period of several weeks. Although the outcome at the end of this period is an important indicator of treatment success, substantial uncertainty remains on how an individual's smoking behavior will evolve over time. Therefore it is of interest to predict long-term smoking cessation success based on short-term clinical observations. We develop a Bayesian method for prediction, based on a cure-mixture frailty model we proposed earlier, that describes the process of transition between abstinence and smoking. Specifically we propose a two-stage prediction algorithm that first uses importance sampling to generate subject-specific frailties from their posterior distributions conditional on the observed data, then samples predicted future smoking behavior trajectories from the estimated model parameters and sampled frailties. We apply the method to data from two randomized smoking cessation trials comparing bupropion to placebo. Comparisons of actual smoking status at one year with predictions from our model and from a variety of empirical methods suggest that our method gives excellent predictions.

Original languageEnglish (US)
Pages (from-to)1321-1329
Number of pages9
JournalBiometrics
Volume67
Issue number4
DOIs
StatePublished - Dec 1 2011

Keywords

  • Bayesian inference
  • Frailty model
  • Importance sampling
  • Prediction
  • ROC curves
  • Smoking cessation

ASJC Scopus subject areas

  • Statistics and Probability
  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)
  • Agricultural and Biological Sciences(all)
  • Applied Mathematics

Fingerprint Dive into the research topics of 'Prediction of individual long-term outcomes in smoking cessation trials using frailty models'. Together they form a unique fingerprint.

  • Cite this